de Goffau, Marcus C.
Lager, Susanne
Sovio, Ulla
Gaccioli, Francesca
Cook, Emma
Peacock, Sharon J.
Parkhill, Julian
Charnock-Jones, D. Stephen
Smith, Gordon C. S.
Article History
Received: 16 January 2019
Accepted: 28 June 2019
First Online: 31 July 2019
Change Date: 1 October 2019
Change Type: Correction
Change Details: An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: J.P. reports grants from Pfizer, personal fees from Next Gen Diagnostics, outside the submitted work; S.J.P. reports personal fees from Specific, personal fees from Next Gen Diagnostics, outside the submitted work; D.S.C.-J. reports grants from GlaxoSmithKline Research and Development, outside the submitted work and non-financial support from Roche Diagnostics, outside the submitted work; G.C.S.S. reports grants and personal fees from GlaxoSmithKline Research and Development, personal fees and non-financial support from Roche Diagnostics, outside the submitted work; D.S.C.-J. and G.C.S.S. report grants from Sera Prognostics, non-financial support from Illumina, outside the submitted work. M.C.d.G., S.L., U.S., F.G. and E.C. have nothing to disclose.